Clinical Trial Update: TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary [Phase 2]

View source ↗

Summary

Phase 2 trial TEACO tested a combination of Taxotere (docetaxel), Eloxatin (oxaliplatin), and Avastin (bevacizumab) in ovarian cancer. The study completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-08-23